Equally high efficacy of 4, 7 and 10-day triple therapies to eradicate Helicobacter pylori infection in patients with ulcer disease

Alimentary Pharmacology and Therapeutics

Volumn 14, Issue 8, 2000, Pages 1065-1070

  Hurenkamp, G J B ^a   Van Der Ende, A ^a   Grundmeijer, H G L M ^a   Tytgat, G N J ^a   Van Der Hulst, R W M ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Department of Gastroenterology ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CLARITHROMYCIN; MACROLIDE; METRONIDAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ERADICATION THERAPY; FEMALE; GASTROINTESTINAL INFECTION; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH BIOPSY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CLARITHROMYCIN; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; STOMACH ULCER;

EID: 0033858682     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2000.00800.x     Document Type: Article

References (23)

1. 1 EHPSG. Current European concepts in the management of Helicobacter pylori infection. The Maastricht consensus report. Gut 1997; 41: 8-13.
2. 2 Van der Hulst RWM, Köycu B, Keller JJ, Bruno M, Rauws EAJ, Tytgat GNJ. Prevention of ulcer recurrence after successful eradication of H. pylori infection: a prospective 10 year followup study. Gastroenterology 1997; 113: 1082-6.
3. 3 Rubin GP, Meineche-Schmidt V, Roberts AP, Childs SM, de Wit NJ. The management of Helicobacter pylori in primary care: Guidelines from the ESPCG. Eur J Gen Pract 1999; 5: 98-104.
4. 4 Graham DY, Lew GM, Malaty HM, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992; 102: 493-6.
5. 5 Noach LA, Langenberg WL, Bertola MA, Dankert J, Tytgat GNJ. Impact of metronidazole resistance on the eradication of Helicobacter pylori. Scand J Infect Dis 1994; 26: 321-7.
6. 6 Weel JF, van der Hulst RWM, Gerrits Y, Tytgat GNJ, van der Ende A, Dankert J. Heterogenity in susceptibility to metronidazole among Helicobacter pylori isolates from patients with gastritis or peptic ulcer disease. J Clin Microbiol 1996; 34: 2158-62.
7. 7 Murnick DE, Peer BJ. Laser-based analysis of carbon isotope ratios. Science 1994; 263: 945-7.
8. 13C-urea breath testing: a prospective diagnostic European multicentre study. Aliment Pharmacol Ther 1999; 13: 1171-7.
9. 9 Gardner MJ, Altman DG. Confidence Interval Analysis. Statistical software published by British Medical Journal, London, 1989.
10. 10 Gisbert JP, Boixeda D, Bermejo F, et al. Omeprazole plus 2 antibiotics for the eradication of H. pylori, are 5 days of treatment sufficient? Rev Clin Esp 1998; 198: 655-9.
11. 11 Zanten SJ, Bradette M, Farley A, Leddin D, Lind T, et al. The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy. Aliment Pharmacol Ther 1999; 13: 289-95.
12. 12 Lind T, Megraud F, Unge P, Bayerdorffer E, O'morain C, et al. The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. Gastroenterology 1999; 116: 248-53.
13. 13 Lind T, van Veldhuyzen Zanten S, Unge P, Spiller R, et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I study. Helicobacter 1996; 1: 138-44.
14. 14 Huang WH, Ho AS, Shyu RY, Lee SC, Lee MMS, Hsu CT. New one-week low-dose triple therapy for the treatment of duodenal ulcer with Helicobacter pylori infection. Chinese Med J (Taipei) 1998; 61: 448-55.
15. 15 Kobler E, Werth B, Wust W, Reinhart WH. Cost-effectiveness of short-term triple therapy for eradication of Helicobacter pylori infection in ulcer disease. J Suisse Med 1997; 127: 14S-16S.
16. 16 Caselli M, Trevisani L, Tursi A, et al. Short-term low-dose triple therapy with azithromycin, metronidazole and lansoprazole appears highly effective for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1997; 9: 45-8.
17. 17 Van't Hoff BWM, van der Hulst RWM, Tytgat GNJ, Dankert J, van der Ende A. Antimicrobial susceptibility of Helicobacter pylori in Amsterdam. Gut 1999; 45(Suppl. V): A185 (Abstract).
18. 18 Lerang F, Moum B, Haug JB, et al. Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance? Am J Gastroenterol 1997; 92: 248-53.
19. 19 Peitz U, Nusch A, Tillenburg B, et al. Impact of treatment duration and metronidazole resistance on H. pylori cure with omeprazole, metronidazole and clarithromycin. Gastroenterology 1997; 112: A255(Abstract).
20. 20 Georgopoulos S, Karatapanis S, Menstis A, Manolatos D, Vretou V, Artikis V. Comparison of two short-term, triple therapies based on clarithromycin in the eradication of Helicobacter pylori. Gastroenterology 1997; 112: A125 (Abstract).
21. 21 Buckley MJM, Xia HX, Hyde DM, Keane CT, O'Morain CA. Metronidazole resistance reduces efficacy of triple therapy and leads to secondary clarithromycin resistance. Dig Dis Sci 1997; 42: 2111-5.
22. 22 Liu WZ, Xiao SD, Shi Y, et al. Furazolidone-containing short-term triple therapies are effective in the treatment of Helicobacter pylori infection. Aliment Pharmacol Ther 1999; 13: 317-22.
23. 23 Van der Hulst RWM, van der Ende A, Dekker FW, et al. Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year follow-up study. Gastroenterology 1997; 113: 25-30.